2026 International Symposium for Malignant Mesothelioma | October 23, 2026 | The Woodlands, Texas
Presented by Alexandra Lebensohn, MS
What can our genes tell us about mesothelioma? This session will explore the role genetics play in mesothelioma, including what we know about genetic changes within tumors and inherited genetic risk. We’ll take a closer look at BAP1, a gene that has been linked to mesothelioma and other cancers, and discuss how BAP1 mutations can influence cancer risk, research, and potentially treatment. Join us to learn how advances in genetics are helping researchers better understand mesothelioma and move toward more personalized approaches to care.
This is a recording of a session at the 2026 International Symposium on Malignant Mesothelioma. This symposium is made possible by our generous sponsors: Belluck and Fox, LLP; Dean Omar Branham Shirley, LLP; Maune Raichle Hartley French & Mudd, LLC (MRHFM); The Gori Law Firm; MERCK; AstraZeneca; Early Lucarelli Sweeney & Meisenkothen
Find other recorded sessions and more information at www.curemeso.org/symposium
